Deckers Outdoor Corp. 10-K Summary (Fiscal Year Ended Dec 31, 1997)
Business Context and Reporting Period
This Annual Report on Form 10-K covers the fiscal year ended December 31, 1997, for Deckers Outdoor Corporation. The Company designs, produces, and markets innovative footwear and apparel under four primary brands: Teva (sports sandals and apparel), Simple (casual footwear), Ugg (sheepskin boots), and Picante (casual apparel). The Company sold approximately 3.865 million pairs of footwear in 1997. Operations are heavily dependent on foreign manufacturing, primarily in the Far East, Mexico, and Australia.
Key Financial Metrics
| Metric | 1997 | 1996 | 1995 |
|---|---|---|---|
| Net Sales | $106,713,000 | $101,838,000 | $102,334,000 |
| Gross Profit | $44,260,000 | $40,829,000 | $36,478,000 |
| Gross Margin | 41.5% | 40.1% | 35.6% |
| Net Earnings | $4,524,000 | $3,656,000 | $1,436,000 |
| Net Earnings Per Share (Diluted) | $0.50 | $0.39 | $0.13 |
| Operating Cash Flow | $8,901,000 | $8,921,000 | $4,861,000 |
| Total Assets | $74,693,000 | $74,897,000 | $74,917,000 |
| Long-Term Debt | $7,983,000 | $10,290,000 | $15,170,000 |
| Working Capital | $39,222,000 | $39,730,000 | $43,769,000 |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 4.8% to $106.7 million, driven primarily by a 40.9% surge in Teva sales ($61.9 million), which now represents 58.0% of total net sales.
- Brand Performance: While Teva grew significantly, Simple sales declined 19.8% and Ugg sales dropped 38.2% due to reduced demand, pricing pressures, and inventory carry-over from the prior year.
- Profitability: Net earnings rose 23.7% to $4.5 million. Gross margin improved to 41.5% due to reduced close-outs on Teva and Ugg products, partially offset by higher Simple close-outs.
- One-Time Items: The Company incurred a $500,000 loss on the closure of its California manufacturing facility in March 1997. Additionally, a $2.6 million settlement was reached regarding the Ugg acquisition earn-out, with $2.0 million paid in January 1998.
- Debt Reduction: Long-term debt decreased by approximately $2.3 million as the Company repaid borrowings under its credit facility.
Guidance, Outlook, and Risks
- 1998 Outlook: Management expects Teva sales to be relatively flat on a calendar basis in 1998 due to a fourth-quarter 1997 early delivery program that pulled $5-6 million of sales forward. Simple sales are expected to remain flat to slightly down, while Ugg sales are projected to increase.
- Expense Outlook: Operating expenses as a percentage of sales are expected to increase in 1998 due to planned spending on advertising, R&D, and international expansion.
- Key Risks:
- Teva License: The Company's primary revenue source relies on exclusive licenses with Mark Thatcher expiring in August 2001. Termination would have a material adverse effect.
- Anti-Dumping Duties: European anti-dumping duties (49.2%) on footwear from China/Indonesia may impact Teva imports into Europe if specific styles are deemed covered.
- Weather Sensitivity: Sales of Teva and Ugg are highly sensitive to weather conditions, including the "El Nino" phenomenon.
- Foreign Manufacturing: Virtually all footwear is manufactured overseas, exposing the Company to supply chain disruptions, currency fluctuations, and trade barriers.
Investor Verification Checklist
- Verify the status of negotiations to extend the Teva(R) licensing agreements beyond August 2001.
- Monitor the resolution of the European anti-dumping duty dispute regarding Teva Valkyrie and Storm styles.
- Assess the impact of the $2.0 million Ugg settlement payment due in January 1998 on cash flow.
- Review the Company's ability to maintain gross margins given the decline in higher-priced Ugg sales and the shift in product mix.
- Confirm the Company's compliance with financial covenants in its $25 million revolving credit facility.